Real-time enrollment status for this small cell lung cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 1:53 PM UTC
| NCT Number | NCT05882058 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 204 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | July 23, 2026 (Jul 23, 2026) |
As of October 15, 2026: Clinical trial NCT05882058 is currently recruiting participants. This phase2 study for small cell lung cancer is actively seeking new participants at 16 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05882058 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05882058 was last updated Jul 23, 2026 (July 23, 2026). HelloStudys verifies this status automatically.